The Post Traumatic Stress Disorder Market To Surge with a CAGR of 8.3% in the 7MM During the Study Period (2019-32) | DelveInsight

September 01 01:10 2022
The Post Traumatic Stress Disorder Market To Surge with a CAGR of 8.3% in the 7MM During the Study Period (2019-32) | DelveInsight

DelveInsight’s Post Traumatic Stress Disorder Market Insights report includes a comprehensive understanding of current treatment practices, Post Traumatic Stress Disorder emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.

 

The dynamics of the Post-Traumatic Stress Disorder market is anticipated to change as the key players, such as Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical and Bionomics Limited are involved in the development of Post-Traumatic Stress Disorder treatment. The projected introduction of these methods might get an advantage in Post-Traumatic Stress Disorder market space due in the course.

 

Key Takeaways from the Post Traumatic Stress Disorder Market

  • As per DelveInsight analysis, the Post Traumatic Stress Disorder market size was over USD 1,740.2 billion in 2021, which is further expected to increase by 2032.
  • As per the estimates, the total Post Traumatic Stress Disorder diagnosed 12-month prevalent cases in the 7MM was more than 5 million in 2021. 
  • Key Post Traumatic Stress Disorder companies such as Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Nobilis Therapeutics,H. Lundbeck A/S, Boehringer Ingelheim, AstraZeneca, Remedy, Pfizer, Tonix Pharmaceuticals, Inc., and others are currently working to develop drugs for Resistant Hypertension that will launch in the Post Traumatic Stress Disorder market in the upcoming years.
  • The Post Traumatic Stress Disorder therapies in the pipeline include JZP150, NYX-783, Rexulti (brexpiprazole) and Zoloft (sertraline) combination, BNC210, and others.
  • The Post Traumatic Stress Disorder testing market is expected to grow significantly owing to an increase in prevalence due to increase in life stressors, traumatic event,less competitive scenario, and increased initiatives to create public awareness and knowledge of the disease., The growth in the market 

 

Download Sample Report- https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market

 

Post-Traumatic Stress Disorder Overview

Post Traumatic Stress Disorder (PTSD) has been defined as “the complex physical, cognitive, emotional, and behavioral consequences of psychological trauma.” It is characterized by intrusive thoughts, nightmares, flashbacks to past traumatic events, avoidance of traumatic reminders, hypervigilance, and sleep disturbance, all of which contribute to significant social, occupational, and interpersonal dysfunction. Post Traumatic Stress Disorder causes include feelings like intense fear, helplessness, and horror.

 

Post-Traumatic Stress Disorder Symptoms

Post-Traumatic Stress Disorder symptoms can occur as soon as a month after a stressful experience, but they can also appear years later. These symptoms generate substantial issues in social and work circumstances, as well as in relationships. They can also impair one’s capacity to carry out routine everyday chores. Post Traumatic Stress Disorder symptoms are classified into four types: intrusive recollections, avoidance, unfavorable changes in thinking and mood, and changes in physical and emotional reactions. Symptoms may change over time or from person to person. 

 

Post-Traumatic Stress Disorder Diagnosis

For the Post Traumatic Stress Disorder diagnosis, the doctor will most likely perform a physical exam to rule out any medical issues that may be causing the symptoms – a psychological evaluation that includes a discussion of the signs and symptoms, as well as the event or events that precipitated them, and will employ the criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

 

Post-Traumatic Stress Disorder Epidemiology Segmentation

  • Post-Traumatic Stress Disorder Prevalence population
  • Post-Traumatic Stress Disorder Diagnosed prevalent Cases
  • Post-Traumatic Stress Disorder Gender-specific Cases
  • Post-Traumatic Stress Disorder Severity-specific Cases
  • Post-Traumatic Stress Disorder Age-specific Cases
  • Total Post-Traumatic Stress Disorder Treated cases

 

Post-Traumatic Stress Disorder Treatment Market

A multidimensional strategy is used in the Post-Traumatic Stress Disorder treatment for patients. Patient education, social support, and anxiety control through psychotherapy and psychopharmacological intervention are all treatment possibilities. Patient education and social support are critical early measures for engaging the patient and mitigating the impact of the traumatic experience. Local and national support groups can assist to de-stigmatize mental health diagnoses and emphasize that Post Traumatic Stress Disorder symptoms are more than just a reaction to stress and require treatment. Family and friend support fosters understanding and acceptance, which may lessen survivor guilt. Psychotherapy and counseling, medicine, or a mix of the two are commonly used in Post-Traumatic Stress Disorder treatment.

 

Post-Traumatic Stress Disorder Pipeline Therapies and Key Players

  • JZP150: Jazz Pharmaceuticals
  • NYX-783: Aptinyx
  • BNC210: Bionomics Limited
  • Rexulti (brexpiprazole) and Zoloft (sertraline) combination: Otsuka Pharmaceutical/ Lundbeck

 

Post-Traumatic Stress Disorder Market Dynamics

The introduction of novel drugs and classes of new therapeutic drugs for treatment into the Post Traumatic Stress Disorder market will give PTSD patients hope as a treatment option and may have a significant positive impact on the Post Traumatic Stress Disorder market. Moreover, new diagnostic categories based on PTSD such as Prolonged duress stress disorder, post-traumatic mourning disorder, post-traumatic relationship syndrome, post-traumatic dental care anxiety, and post-traumatic abortion syndrome have all been proposed which will further boost the Post Traumatic Stress Disorder market. Furthermore, the increase in the prevalence and rise in initiatives to create public awareness and knowledge of the disease are also contributing to the growth of the Post Traumatic Stress Disorder market. In addition, a less competitive scenario will create an opportunity for the new players to enter into the Post Traumatic Stress Disorder market

 

Post-Traumatic Stress Disorder Market Growth Factors

However, certain factors are limiting the growth of the Post Traumatic Stress Disorder market. The main drawback of PTSD is that it is associated with high rates of comorbidities, psychiatric and medical diseases, as well as alcohol and drug abuse, resulting in poor QOL and poor physical health, thus impeding the growth of the Post Traumatic Stress Disorder market. In addition, the heterogeneity of the symptoms and delayed onset of PTSD are acting as a barrier to the growth of the Post Traumatic Stress Disorder market. Moreover, with the expiration of patent protection for many pharmaceuticals and rising health-care costs, the entry of generics occurs, posing a significant challenge to the Post Traumatic Stress Disorder market. 

 

Scope of the Post Traumatic Stress Disorder Market Report

  • Study Period: 2019-2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Post Traumatic Stress Disorder Companies: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Nobilis Therapeutics,H. Lundbeck A/S, Boehringer Ingelheim, AstraZeneca, Remedy, Pfizer, Tonix Pharmaceuticals, Inc., and others
  • Key Post Traumatic Stress Disorder Pipeline Therapies: JZP150, NYX-783, Rexulti (brexpiprazole) and Zoloft (sertraline) combination, BNC210, and others
  • Post Traumatic Stress Disorder Therapeutic Assessment: Post Traumatic Stress Disorder current marketed and emerging therapies
  • Post Traumatic Stress Disorder Market Dynamics:  Post Traumatic Stress Disorder market drivers and barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Post Traumatic Stress Disorder Market Access and Reimbursement

 

Request Sample Report- https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market

 

Table of content

1. Key Insights

2. Report Introduction

3. Post-Traumatic Stress Disorder Market Overview at a Glance

4. Executive Summary of Post-Traumatic Stress Disorder (PTSD)

5. Epidemiology and Market Methodology

6. Disease Background and Overview

7. Diagnosis of Post-Traumatic Stress Disorder

8. Treatment of Post-Traumatic Stress Disorder

9. Diagnosis and Treatment Guidelines

10. Conclusion

11. Epidemiology and Patient Population

12. Patient Journey

13. Key Endpoints in Post-Traumatic Stress Disorder (PTSD) Clinical Trials

14. Emerging Therapies

15. Conjoint Analysis

16. Post-Traumatic Stress Disorder: 7 Major Market Analysis

17. Market Outlook

18. Market Access and Reimbursement

19. KOL Views

20. Market Drivers

21. Market Barriers

22. SWOT Analysis

23. Unmet Needs

24. Appendix

25. DelveInsight Capabilities

26. Disclaimer

27. About DelveInsight

 

Do you have any query related to the report? Visit here- https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/